COMPARATIVE EFFECT OF FAMOTIDINE AND CIMETIDINE ON THE PHARMACOKINETICS OF THEOPHYLLINE IN NORMAL VOLUNTEERS

被引：23

作者：

LIN, JH ^{[1
]}

CHREMOS, AN ^{[1
]}

CHIOU, R ^{[1
]}

YEH, KC ^{[1
]}

WILLIAMS, R ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,DRUG STUDIES UNIT,SAN FRANCISCO,CA 94143

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 24卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1987.tb03228.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：669 / 672

页数：4

共 16 条

[1]

BAURMANN JH, 1982, ANN ALLERGY, V48, P100

[2]

CHIOU R, 1987, IN PRESS J CHROMATOG

[3]

Hansten PD, 1979, DRUG INTERACTIONS

[4]

HETZEL D, 1979, LANCET, V2, P639

[5] CIMETIDINE INTERACTION WITH PHENYTOIN [J].

HETZEL, DJ ;

BOCHNER, F ;

HALLPIKE, JF ;

SHEARMAN, DJC ;

HANN, CS .

BRITISH MEDICAL JOURNAL, 1981, 282 (6275) :1512-1512

[6] FAMOTIDINE, A NEW, POTENT, LONG-ACTING HISTAMINE H2-RECEPTOR ANTAGONIST - COMPARISON WITH CIMETIDINE AND RANITIDINE IN THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME [J].

HOWARD, JM ;

CHREMOS, AN ;

COLLEN, MJ ;

MCARTHUR, KE ;

CHERNER, JA ;

MATON, PN ;

CIARLEGLIO, CA ;

CORNELIUS, MJ ;

GARDNER, JD ;

JENSEN, RT .

GASTROENTEROLOGY, 1985, 88 (04) :1026-1033

[7]

JACKSON J E, 1980, Pharmacologist, V22, P231

[8] BIOAVAILABILITY ASSESSMENT UNDER QUASI-STATE AND NONSTEADY-STATE CONDITIONS .1. THEORETICAL CONSIDERATIONS [J].

KWAN, KC ;

BONDI, JV ;

YEH, KC .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (10) :1639-1642

[9]

LIN JH, 1986, DRUG METAB DISPOS, V14, P649

[10] MK-208, A NOVEL HISTAMINE H-2-RECEPTOR INHIBITOR WITH PROLONGED ANTISECRETORY EFFECT [J].

MCCALLUM, RW ;

CHREMOS, AN ;

KULJIAN, B ;

TUPYVISICH, MA ;

HUBER, PB .

DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (12) :1139-1144

← 1 2 →